Photonic Crystal Microarray for Label-Free Biosensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current photonic crystal microarray designs for multiple analyte sensing suffer from poor optical confinement, reduced signal-to-noise ratio, and high temperature processing issues that compromise biomolecule functionality, limiting their sensitivity and throughput for detecting multiple biomolecules simultaneously.

Innovation Solution

A photonic crystal microarray structure featuring a semiconductor core with a triangular lattice of holes, integrated with a two-dimensional photonic crystal waveguide and microcavities, allowing for high dielectric constant core and low dielectric constant cladding, enabling efficient light coupling and minimizing temperature-induced biomolecule denaturation, with a novel lithography scheme that preserves biomolecule functionality at room temperature.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If one-dimensional photonic crystal grating structures are used for multiple analyte sensing, then the device can measure resonant peak reflected wavelengths, but the sensors suffer from wide linewidths of resonant peaks due to one-dimensional confinement, reducing measurement precision

Engineering Contradiction:
Improvemultiple analyte sensing capabilityVSAvoidresonant peak linewidth
Core Design Contradiction:
Adaptability or versatilityVSMeasurement precision

Solution Approach 1:

The patent transitions from one-dimensional photonic crystal grating structures to two-dimensional photonic crystal microcavity arrays. This dimensional change enables narrow resonant linewidths while supporting multiple analyte sensing through spatially separated microcavities coupled to a common waveguide, resolving the contradiction between versatility and measurement precision.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Productivity

If measurements are made from each sensor element in a serial process, then individual sensing can be performed, but multiple sources and detectors are required for parallel sensing beyond a single element, increasing device complexity

Engineering Contradiction:
Improvemeasurement throughputVSAvoidnumber of sources and detectors
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent merges multiple sensor elements (photonic crystal microcavities) into a single integrated structure where multiple microcavities are coupled to a common photonic crystal waveguide. This allows parallel measurement of multiple analytes using a single light source and detector, achieving high throughput while reducing device complexity.

Inventive Principle:
Principle #5Merging (Combining)

3Ease of manufacture

If one-dimensional photonic crystal microcavities are used, then coupling to ridge waveguides can be achieved, but poor optical confinement and reduced group velocity in two-dimensional photonic crystal waveguides are not utilized, limiting signal-to-noise ratio

Engineering Contradiction:
Improvewaveguide couplingVSAvoidsignal-to-noise ratio
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent employs two-dimensional photonic crystal waveguides instead of one-dimensional structures. The 2D photonic bandgap provides superior optical confinement and enables utilization of the slow light effect through reduced group velocity, significantly enhancing signal-to-noise ratio while maintaining manufacturability through standard fabrication processes.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

4Ease of manufacture

If high temperature processing is used in standard lithography, then photonic crystal structures can be fabricated, but biomolecule functionality is compromised or destroyed, limiting biosensing capability

Engineering Contradiction:
Improvelithography fabricationVSAvoidbiomolecule functionality
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent incorporates biomolecules onto the photonic crystal microcavities before final fabrication steps or uses low-temperature processing techniques. This preliminary action ensures biomolecules are in place before any thermal processing occurs, or protects them from high temperatures that would denature them, maintaining biosensing functionality while enabling fabrication.

Inventive Principle:
Principle #10Preliminary action

5Productivity

If multiple photonic crystal microcavities are arrayed along a single waveguide, then simultaneous parallel sensing can be performed, but coupling between waveguides and microcavities introduces transmission loss at each interface, reducing signal-to-noise ratio

Engineering Contradiction:
Improveparallel sensing capabilityVSAvoidsignal-to-noise ratio
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent merges multiple photonic crystal microcavities into a unified structure coupled to a single photonic crystal waveguide. This integration minimizes the number of interfaces between waveguides and microcavities, reducing cumulative transmission losses and maintaining high signal-to-noise ratio while enabling parallel sensing of multiple analytes.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This design enhances sensitivity and measurement throughput by allowing simultaneous detection of multiple analytes with high signal-to-noise ratio and preserves biomolecule functionality, reducing the need for labeling and costs associated with biomolecule labeling, while maintaining biomolecule stability and specificity.

Implementation Method 1

Tight confinement of the optical field in photonic crystal microcavities leads to a strong interaction with the surrounding ambient in the vicinity of the microcavity

Methodology Applied
Scientific EffectOptical confinement: Total Internal Reflection

Implementation Method 2

leads to large sensitivity to changes in refractive index of the ambient

Methodology Applied
Scientific EffectRefractive index sensitivity: Refraction

Implementation Method 3

do not utilize the slow light effect due to reduced group velocity in two-dimensional photonic crystal waveguides that would otherwise enhance coupling efficiency and thereby improve signal-to-noise ratio of sensing

Methodology Applied
Scientific EffectSlow light effect: Dispersion (of waves)

Data Source

PatentUS9579621B2Method for label-free multiple analyte sensing, biosensing and diagnostic assay
Publication Date: 2017.02.28 OMEGA OPTICS
  • US9579621B2 patent drawing
  • US9579621B2 patent drawing
  • US9579621B2 patent drawing

AI summary

Methods and systems for label-free multiple analyte sensing, biosensing and diagnostic assay chips consisting of an array of photonic crystal microcavities along a single photonic crystal waveguide are disclosed. The invention comprises an on-chip integrated microarray device that enables detection and identification of multiple species to be performed simultaneously using optical techniques leading to a high throughput device for chemical sensing, biosensing and medical diagnostics. Other embodiments are described and claimed.